Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021.

Various: Krebs in Deutschland für 2015/2016. Gemeinsame Publikation des Zentrums für Krebsregisterdaten und der Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V, vol. 12. Berlin: Robert Koch-Institut Berlin; 2019.

Domper Arnal MJ, Ferrández Arenas Á, Lanas AÁ. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21(26):7933–43.

PubMed  PubMed Central  Google Scholar 

Eyck BM, van Lanschot JJB, Hulshof MCCM, et al. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial. J Clin Oncol. 2021;39(18):1995–2004.

CAS  PubMed  Google Scholar 

van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84.

PubMed  Google Scholar 

Ochi M, Murakami Y, Nishibuchi I, et al. Long-term results of definite chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma. J Radiat Res. 2021;62(1):142–8.

CAS  PubMed  Google Scholar 

Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol. 2005;6(9):659–68.

PubMed  Google Scholar 

Won E, Ilson DH. Management of localized esophageal cancer in the older patient. Oncologist. 2014;19:367–74.

PubMed  PubMed Central  Google Scholar 

Molena D, Stem M, Blackford AL, et al. Esophageal cancer treatment is underutilized among elderly patients in the USA. J Gastrointest Surg. 2017;21:126–36.

PubMed  Google Scholar 

Tougeron D, di Fiore F, Thureau S, et al. Safety and outcome of definite chemoradiotherapy in elderly patients with oesophageal cancer. Br J Cancer. 2008;99:1586–92.

CAS  PubMed  PubMed Central  Google Scholar 

Walter F, Böckle D, Schmidt-Hegemann NS, et al. Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definite or neoadjuvant radio(chemo)therapy: a retrospective single center analysis. Radiat Oncol. 2018;13:93.

PubMed  PubMed Central  Google Scholar 

Chen RC, Royce TJ, Extermann M, et al. Impact of age and comorbidity on treatment and outcomes in elderly cancer patients. Semin Radiat Oncol. 2012;22(4):265–71.

PubMed  Google Scholar 

OECD (2022), Elderly population (indicator). https://doi.org/10.1787/8d805ea1-en (Last accessed on 03 September 2022).

Orimo H, Ito H, Suzuki T, et al. Reviewing the definition of “elderly.” Geriatr Gerontol Int. 2006;6(3):149–58.

Google Scholar 

Caterino JM, Valasek T, Werman HA. Identification of an age cutoff for increased mortality in patients with elderly trauma. Am J Emerg Med. 2010;28(2):151–8.

PubMed  Google Scholar 

Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc. 1958;53:457–81.

Google Scholar 

Cox DR, Oakes D. Analysis of survival data. London: Chapman Hall; 1984.

Google Scholar 

Common Terminology Criteria for Adverse Events (CTCAE) Version 5. Published: November 27, 2017. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute.

Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649–55.

CAS  PubMed  Google Scholar 

Herskovic A, Martz K, Al Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593–8.

CAS  PubMed  Google Scholar 

Nienhueser H, Kunzmann R, Sisic L, et al. Surgery of gastric cancer and esophageal cancer: does age matter? J Surg Oncol. 2015;112(4):387–95.

PubMed  Google Scholar 

Camerlo A, D’Journo XB, Ouattara M, et al. Adenocarcinoma of the esophagus and esophagogastric junction in patients older than 70 years: results of neoadjuvant radiochemotherapy followed by transthoracic esophagectomy. J Visc Surg. 2012;149(3):e203–10.

CAS  PubMed  Google Scholar 

Schmidt T, Sicic L, Blank S, et al. Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas. Br J Cancer. 2014;110(7):1712–20. https://doi.org/10.1038/bjc.2014.94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruol A, Portale G, Castoro C, et al. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer. Ann Surg Oncol. 2007;14(11):3243–50.

PubMed  Google Scholar 

Bollschweiler E, Plum P, Mönig SP, et al. Current and future treatment options for esophageal cancer in the elderly. Expert Opin Pharmacother. 2017;18(10):1001–10.

CAS  PubMed  Google Scholar 

Lu X, Wu H, Wang J, et al. Short- and long-term outcomes of definitive chemoradiotherapy in patients with esophageal carcinoma aged ≥75 years. Mol Clin Oncol. 2014;2(2):297–301.

PubMed  Google Scholar 

Trumper M, Ross PJ, Cunningham D, et al. Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: a pooled analysis of three clinical trials. Eur J Cancer. 2006;42(7):827–34.

CAS  PubMed  Google Scholar 

Song T, Zhang X, Fang M, et al. Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer. Onco Targets Ther. 2015;8:3087–94.

CAS  PubMed  PubMed Central  Google Scholar 

Zhao L, Zhou Y, Pan H, et al. Radiotherapy alone or concurrent chemoradiation for esophageal squamous cell carcinoma in elderly patients. J Cancer. 2017;8(16):3242–50.

PubMed  PubMed Central  Google Scholar 

Paul G, Bohle W, Zoller W. Risk factors for the development of esophagorespiratory fistula in esophageal cancer. J Gastrointestin Liver Dis. 2019;28(3):265–70.

PubMed  Google Scholar 

Xu Y, Cui H, Dong T, et al. Integrating clinical data and attentional CT imaging features for esophageal fistula prediction in esophageal cancer. Front Oncol. 2021;11: 688706.

PubMed  PubMed Central  Google Scholar 

Münch S, Pigorsch SU, Feith M, et al. Comparison of neoadjuvant chemoradiation with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus. Radiat Oncol. 2017;12:182.

PubMed  PubMed Central  Google Scholar 

Münch S, Pigorsch SU, Devečka M, et al. Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus. Radiat Oncol. 2018;13:139.

PubMed  PubMed Central  Google Scholar 

Qu XM, Biagi JJ, Hopman WM, et al. Shifting practice in definitive chemoradiation for localized esophageal cancer. Curr Oncol. 2017;24(5):e379–87.

CAS  PubMed  PubMed Central  Google Scholar 

Honing J, Smit JK, Muijs CT, et al. A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients. Ann Oncol. 2014;25(3):638–43.

CAS  PubMed  PubMed Central  Google Scholar 

Blom RL, Sosef MN, Nap M, et al. Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma. Dis Esophagus. 2014;27(4):380–7.

CAS  PubMed  Google Scholar 

Verma V, Haque W, Zheng D, et al. Patterns of care and outcomes of elderly esophageal cancer patients not meeting age-based criteria of the CROSS trial. Am J Clin Oncol. 2019;42(1):67–74.

PubMed  Google Scholar 

Haefner MF, Lang K, Verma V, et al. Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer. Strahlenther Onkol. 2018;194:116–24.

PubMed  Google Scholar 

Minsky BD, Pajak TF, Ginsberg RJ. INT 0123 (radiation therapy oncology group 94–05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20:1167–74.

CAS  PubMed  Google Scholar 

Qiu G, Zhang W, Wang F, et al. Metastasis patterns and prognosis of elderly patients with esophageal adenocarcinoma in stage IVB: a population-based study. Front Oncol. 2021;11: 625720.

PubMed  PubMed Central  Google Scholar 

Wang J, Wei C, Tucker SL, et al. Predictors of postoperative complications after trimodality therapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2013;86(5):885–91.

PubMed  PubMed Central  Google Scholar 

Mantziari S, Teixeira Farinha H, Bouygues V, et al. Esophageal cancer in elderly patients, current treatment options and outcomes; a systematic review and pooled analysis. Cancers. 2021;13(9):2104.

PubMed  PubMed Central  Google Scholar 

Internullo E, Moons J, Nafteux P, et al. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years. Eur J Cardiothorac Surg. 2008;33(6):1096–104.

PubMed  Google Scholar 

Morita M, Egashira A, Yoshida R, et al. Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus. J Gastroenterol. 2008;43(5):345–51.

PubMed  Google Scholar 

Alexiou C, Beggs D, Salama FD, et al. Surgery for esophageal cancer in elderly patients: the view from Nottingham. J Thorac Cardiovasc Surg. 1998;116(4):545–53.

CAS  PubMed  Google Scholar 

Matsumoto Y, Kimura K, Zhou Q, et al. Treatments and outcomes of older patients with esophageal cancer: comparison with younger patients. Mol Clin Oncol. 2019;11(4):383–9.

PubMed  PubMed Central  Google Scholar 

Prytherch DR, Whiteley MS, Higgins B, et al. POSSUM and Portsmouth POSSUM for predicting mortality. Physiological and operative severity score for the enumeration of mortality and morbidity. Br J Surg. 1998;85(9):1217–20.

CAS  PubMed  Google Scholar 

Tekkis PP, McCulloch P, Poloniecki JD, et al. Risk-adjusted prediction of operative mortality in oesophagogastric surgery with O-POSSUM. Br J Surg. 2004;91(3):288–95.

CAS  PubMed  Google Scholar 

Steyerberg EW, Neville BA, Koppert LB, et al. Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol. 2006;24(26):4277–84.

PubMed